Analyst Ratings January 28, 2026

Evercore Maintains Outperform on Starbucks, Sets $105 Target as Earnings Show Mixed Signals

Analyst reiteration follows a quarter of softer margins and EPS but solid top-line and international strength, with China and licensing activity notable drivers

By Maya Rios SBUX
Evercore Maintains Outperform on Starbucks, Sets $105 Target as Earnings Show Mixed Signals
SBUX

Evercore ISI has reiterated an Outperform rating on Starbucks with a $105.00 price target after the company released first-quarter results that combined an earnings decline and margin compression with stronger-than-expected same-store sales, particularly internationally and in China. The stock traded near $98.54, carries a high P/E ratio, and drew a positive market reaction after a revenue beat.

Key Points

  • Evercore ISI reiterated an Outperform rating on Starbucks with a $105.00 price target while the stock traded near $98.54 and carries a P/E of 61.8.
  • Q1 EPS was $0.56 (an 18% year-over-year decline) - beating Evercore’s estimate of $0.51 but reported as slightly below consensus levels ($0.58 and, in some reports, $0.59), with consolidated operating margin at 10.1%, down 180 basis points year-over-year.
  • Same-store sales outperformed expectations both in the Americas (+4%) and internationally (+5%), with China up 7%; Starbucks reported trailing-12-month revenue of $37.18 billion and a market capitalization of $112.89 billion.

Evercore ISI reaffirmed an Outperform rating and left its price target at $105.00 for Starbucks (NASDAQ:SBUX) after the company reported first-quarter results. The shares were trading around $98.54, close to what InvestingPro lists as fair value, and the company is trading at a price-to-earnings multiple of 61.8.

Earnings and margins

Starbucks reported first-quarter earnings per share of $0.56, an 18% decline from the prior-year period. That result topped Evercore’s internal estimate of $0.51 but was slightly below the consensus expectation of $0.58. In other reporting within the quarter, the company’s EPS was also described as missing analysts’ expectations of $0.59, a 5.08% shortfall. Consolidated operating margin for the quarter stood at 10.1%, down 180 basis points year-over-year.

On a trailing-12-month basis, diluted EPS was $1.63. Street estimates included in the reporting showed analysts projecting EPS of $2.33 for fiscal 2026.

Sales performance in the Americas

Americas same-store sales increased 4%, outpacing both Evercore’s and consensus views of 2%. Management attributed that growth to a 3% increase in transactions and a 1% increase in average ticket. The company also noted that both rewards and non-rewards member activity rose for the first time in eight quarters, supporting the uplift in transactions.

InvestingPro-sourced figures cited in the coverage put Starbucks’ overall revenue growth at 2.79% over the last twelve months, and the company’s market capitalization at $112.89 billion.

International strength and China recovery

International operations outperformed expectations, with same-store sales up 5% versus an estimated 2.5%. China was highlighted for stronger momentum, posting 7% same-store sales growth driven by a 5% increase in transactions and a 2% ticket improvement. The international gains contributed to reported total revenue of $37.18 billion on a trailing-12-month basis.

Pilot programs, licensing and M&A

Starbucks said its "Green Apron" pilot stores are outpacing the broader system on same-store sales by two percentage points, with that advantage attributed entirely to higher transaction volumes. The company also expects a pending transaction with Boyu to close this spring - once completed, the deal will convert roughly 8,000 company-operated locations into licensed stores within the International segment.

Dividend and industry placement

Operating as a significant participant in the Hotels, Restaurants & Leisure industry, Starbucks has maintained dividend payments for 17 consecutive years and currently yields 2.59%.

Market reaction and revenue results

Alongside the EPS figures, Starbucks reported quarterly revenue of $9.9 billion, which exceeded an anticipated $9.62 billion. The revenue beat appeared to influence investor sentiment, with the stock rising roughly 8% in pre-market trading as reported.

Analyst stance and valuation considerations

Evercore’s continued Outperform rating and $105 price target follow the mixed results: an EPS decline and margin compression on one hand, and stronger-than-expected same-store sales, international recovery and a revenue beat on the other. The company’s elevated P/E ratio of 61.8 and proximity of the share price to InvestingPro Fair Value were noted in the coverage alongside carry-through metrics such as trailing EPS and fiscal 2026 forecasts.


The quarter presents a combination of operational strengths in sales and expansion initiatives and challenges in profitability metrics, leaving investors and analysts to weigh revenue momentum and international gains against a compressed operating margin and a high valuation multiple.

Risks

  • Earnings and margin pressure - reported EPS declined 18% year-over-year and consolidated operating margin contracted by 180 basis points, indicating potential near-term profitability headwinds for the consumer discretionary and Restaurants sectors.
  • Valuation risk - the company is trading at a high P/E ratio of 61.8, which could increase downside sensitivity in equity markets if growth expectations are not met.
  • Transaction and closing uncertainty - the planned Boyu acquisition is expected to close this spring and will convert roughly 8,000 stores to licensed locations; any delays or changes could affect International segment plans and investor expectations.

More from Analyst Ratings

HSBC Lowers Synopsys Rating to Hold, Flags 2026 as Transition Year Feb 21, 2026 DA Davidson Cuts Uber Price Target Citing Elevated Investment; Buy Rating Intact Feb 20, 2026 Freedom Capital Markets Raises Freeport-McMoRan to Buy, Cites Copper Supply Tightness Feb 20, 2026 BofA Lifts CF Industries Price Target After Strong Q4 EBITDA; Maintains Underperform Rating Feb 20, 2026 Truist Lifts Tandem Diabetes Price Target as Company Shifts Toward Pharmacy Model Feb 20, 2026